Jinbao Chen
Shanghai, 200062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bufalin inhibits immune escape in metastatic colorectal cancer by regulating M2 macrophage polarization.
Journal: Apoptosis : an international journal on programmed cell death
Published: March 22, 2025
Mechanism Study of Bufalin Reversal of Drug Resistance by Inhibiting Hypoxic Colon Cancer Cell-Induced Polarization of M2 Macrophages.
Journal: Integrative cancer therapies
Published: March 12, 2025
Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer.
Journal: Journal of cancer research and clinical oncology
Published: October 28, 2024
Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells.
Journal: Apoptosis : an international journal on programmed cell death
Published: December 19, 2023
Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway.
Journal: Apoptosis : an international journal on programmed cell death
Published: January 12, 2023
α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway.
Journal: International journal of oncology
Published: June 03, 2022
Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer.
Journal: Cancer management and research
Published: August 13, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026